Changes to reclassification across three cardiovascular prediction models, in the derivation cohort
From model 1 (original SCORE) to model 2 (recalibrated SCORE) . | ||||||||
---|---|---|---|---|---|---|---|---|
Status after follow-up . | Predicted 10-year risk (original SCORE) . | Predicted 10-year risk (recalibrated SCORE) . | Reclassified . | Net correctly reclassified . | ||||
<5% . | >5% . | Increased risk . | Decreased risk . | |||||
Died from CVD (n = 338) | ||||||||
<5% | 67 | 10 | 3% | −11% | ||||
>5% | 47 | 214 | 14% | |||||
Did not die from CVD (n = 14 260) | ||||||||
<5% | 8885 | 288 | 2% | 15% | ||||
>5% | 2377 | 2710 | 17% | |||||
Categorical net reclassification improvement (95% CI) | 0.03 | (−0.01 to 0.08) | P = 0.09 | |||||
Continuous net reclassification improvement (95% CI) | 0.19 | (0.08 to 0.29) | P < 0.0001 |
From model 1 (original SCORE) to model 2 (recalibrated SCORE) . | ||||||||
---|---|---|---|---|---|---|---|---|
Status after follow-up . | Predicted 10-year risk (original SCORE) . | Predicted 10-year risk (recalibrated SCORE) . | Reclassified . | Net correctly reclassified . | ||||
<5% . | >5% . | Increased risk . | Decreased risk . | |||||
Died from CVD (n = 338) | ||||||||
<5% | 67 | 10 | 3% | −11% | ||||
>5% | 47 | 214 | 14% | |||||
Did not die from CVD (n = 14 260) | ||||||||
<5% | 8885 | 288 | 2% | 15% | ||||
>5% | 2377 | 2710 | 17% | |||||
Categorical net reclassification improvement (95% CI) | 0.03 | (−0.01 to 0.08) | P = 0.09 | |||||
Continuous net reclassification improvement (95% CI) | 0.19 | (0.08 to 0.29) | P < 0.0001 |
From model 2 (recalibrated SCORE) to model 3 (HAPIEE SCORE) . | ||||||||
---|---|---|---|---|---|---|---|---|
Status after follow-up . | Predicted 10-year risk (recalibrated SCORE) . | Predicted 10-year risk (HAPIEE SCORE) . | Reclassified . | Net correctly reclassified . | ||||
<5% . | >5% . | Increased risk . | Decreased risk . | |||||
Died from CVD (n = 338) | ||||||||
<5% | 90 | 24 | 7% | 2.4% | ||||
>5% | 16 | 208 | 5% | |||||
Did not die from CVD (n = 14 260) | ||||||||
<5% | 10 671 | 591 | 4% | 0.4% | ||||
>5% | 654 | 2344 | 5% | |||||
Categorical net reclassification improvement (95% CI) | 0.03 | (−0.01 to 0.07) | P = 0.14 | |||||
Continuous net reclassification improvement (95% CI) | 0.44 | (0.33 to 0.55) | P < 0.0001 |
From model 2 (recalibrated SCORE) to model 3 (HAPIEE SCORE) . | ||||||||
---|---|---|---|---|---|---|---|---|
Status after follow-up . | Predicted 10-year risk (recalibrated SCORE) . | Predicted 10-year risk (HAPIEE SCORE) . | Reclassified . | Net correctly reclassified . | ||||
<5% . | >5% . | Increased risk . | Decreased risk . | |||||
Died from CVD (n = 338) | ||||||||
<5% | 90 | 24 | 7% | 2.4% | ||||
>5% | 16 | 208 | 5% | |||||
Did not die from CVD (n = 14 260) | ||||||||
<5% | 10 671 | 591 | 4% | 0.4% | ||||
>5% | 654 | 2344 | 5% | |||||
Categorical net reclassification improvement (95% CI) | 0.03 | (−0.01 to 0.07) | P = 0.14 | |||||
Continuous net reclassification improvement (95% CI) | 0.44 | (0.33 to 0.55) | P < 0.0001 |
From model 1 (original SCORE) to model 3 (HAPIEE SCORE) . | ||||||||
---|---|---|---|---|---|---|---|---|
Status after follow-up . | Predicted 10-year risk (original SCORE) . | Predicted 10-year risk (HAPIEE SCORE) . | Reclassified . | Net correctly reclassified . | ||||
<5% . | >5% . | Increased risk . | Decreased risk . | |||||
Died from CVD (n = 338) | ||||||||
<5% | 60 | 17 | 5% | −8.6% | ||||
>5% | 46 | 215 | 14% | |||||
Did not die from CVD (n = 14 260) | ||||||||
<5% | 8774 | 399 | 3% | 15% | ||||
>5% | 2551 | 2536 | 18% | |||||
Categorical net reclassification improvement (95% CI) | 0.07 | (0.02 to 0.11) | P = 0.005 | |||||
Continuous net reclassification improvement (95% CI) | 0.45 | (0.34 to 0.56) | P < 0.0001 |
From model 1 (original SCORE) to model 3 (HAPIEE SCORE) . | ||||||||
---|---|---|---|---|---|---|---|---|
Status after follow-up . | Predicted 10-year risk (original SCORE) . | Predicted 10-year risk (HAPIEE SCORE) . | Reclassified . | Net correctly reclassified . | ||||
<5% . | >5% . | Increased risk . | Decreased risk . | |||||
Died from CVD (n = 338) | ||||||||
<5% | 60 | 17 | 5% | −8.6% | ||||
>5% | 46 | 215 | 14% | |||||
Did not die from CVD (n = 14 260) | ||||||||
<5% | 8774 | 399 | 3% | 15% | ||||
>5% | 2551 | 2536 | 18% | |||||
Categorical net reclassification improvement (95% CI) | 0.07 | (0.02 to 0.11) | P = 0.005 | |||||
Continuous net reclassification improvement (95% CI) | 0.45 | (0.34 to 0.56) | P < 0.0001 |
CI, confidence interval; CVD, cardiovascular disease.
Changes to reclassification across three cardiovascular prediction models, in the derivation cohort
From model 1 (original SCORE) to model 2 (recalibrated SCORE) . | ||||||||
---|---|---|---|---|---|---|---|---|
Status after follow-up . | Predicted 10-year risk (original SCORE) . | Predicted 10-year risk (recalibrated SCORE) . | Reclassified . | Net correctly reclassified . | ||||
<5% . | >5% . | Increased risk . | Decreased risk . | |||||
Died from CVD (n = 338) | ||||||||
<5% | 67 | 10 | 3% | −11% | ||||
>5% | 47 | 214 | 14% | |||||
Did not die from CVD (n = 14 260) | ||||||||
<5% | 8885 | 288 | 2% | 15% | ||||
>5% | 2377 | 2710 | 17% | |||||
Categorical net reclassification improvement (95% CI) | 0.03 | (−0.01 to 0.08) | P = 0.09 | |||||
Continuous net reclassification improvement (95% CI) | 0.19 | (0.08 to 0.29) | P < 0.0001 |
From model 1 (original SCORE) to model 2 (recalibrated SCORE) . | ||||||||
---|---|---|---|---|---|---|---|---|
Status after follow-up . | Predicted 10-year risk (original SCORE) . | Predicted 10-year risk (recalibrated SCORE) . | Reclassified . | Net correctly reclassified . | ||||
<5% . | >5% . | Increased risk . | Decreased risk . | |||||
Died from CVD (n = 338) | ||||||||
<5% | 67 | 10 | 3% | −11% | ||||
>5% | 47 | 214 | 14% | |||||
Did not die from CVD (n = 14 260) | ||||||||
<5% | 8885 | 288 | 2% | 15% | ||||
>5% | 2377 | 2710 | 17% | |||||
Categorical net reclassification improvement (95% CI) | 0.03 | (−0.01 to 0.08) | P = 0.09 | |||||
Continuous net reclassification improvement (95% CI) | 0.19 | (0.08 to 0.29) | P < 0.0001 |
From model 2 (recalibrated SCORE) to model 3 (HAPIEE SCORE) . | ||||||||
---|---|---|---|---|---|---|---|---|
Status after follow-up . | Predicted 10-year risk (recalibrated SCORE) . | Predicted 10-year risk (HAPIEE SCORE) . | Reclassified . | Net correctly reclassified . | ||||
<5% . | >5% . | Increased risk . | Decreased risk . | |||||
Died from CVD (n = 338) | ||||||||
<5% | 90 | 24 | 7% | 2.4% | ||||
>5% | 16 | 208 | 5% | |||||
Did not die from CVD (n = 14 260) | ||||||||
<5% | 10 671 | 591 | 4% | 0.4% | ||||
>5% | 654 | 2344 | 5% | |||||
Categorical net reclassification improvement (95% CI) | 0.03 | (−0.01 to 0.07) | P = 0.14 | |||||
Continuous net reclassification improvement (95% CI) | 0.44 | (0.33 to 0.55) | P < 0.0001 |
From model 2 (recalibrated SCORE) to model 3 (HAPIEE SCORE) . | ||||||||
---|---|---|---|---|---|---|---|---|
Status after follow-up . | Predicted 10-year risk (recalibrated SCORE) . | Predicted 10-year risk (HAPIEE SCORE) . | Reclassified . | Net correctly reclassified . | ||||
<5% . | >5% . | Increased risk . | Decreased risk . | |||||
Died from CVD (n = 338) | ||||||||
<5% | 90 | 24 | 7% | 2.4% | ||||
>5% | 16 | 208 | 5% | |||||
Did not die from CVD (n = 14 260) | ||||||||
<5% | 10 671 | 591 | 4% | 0.4% | ||||
>5% | 654 | 2344 | 5% | |||||
Categorical net reclassification improvement (95% CI) | 0.03 | (−0.01 to 0.07) | P = 0.14 | |||||
Continuous net reclassification improvement (95% CI) | 0.44 | (0.33 to 0.55) | P < 0.0001 |
From model 1 (original SCORE) to model 3 (HAPIEE SCORE) . | ||||||||
---|---|---|---|---|---|---|---|---|
Status after follow-up . | Predicted 10-year risk (original SCORE) . | Predicted 10-year risk (HAPIEE SCORE) . | Reclassified . | Net correctly reclassified . | ||||
<5% . | >5% . | Increased risk . | Decreased risk . | |||||
Died from CVD (n = 338) | ||||||||
<5% | 60 | 17 | 5% | −8.6% | ||||
>5% | 46 | 215 | 14% | |||||
Did not die from CVD (n = 14 260) | ||||||||
<5% | 8774 | 399 | 3% | 15% | ||||
>5% | 2551 | 2536 | 18% | |||||
Categorical net reclassification improvement (95% CI) | 0.07 | (0.02 to 0.11) | P = 0.005 | |||||
Continuous net reclassification improvement (95% CI) | 0.45 | (0.34 to 0.56) | P < 0.0001 |
From model 1 (original SCORE) to model 3 (HAPIEE SCORE) . | ||||||||
---|---|---|---|---|---|---|---|---|
Status after follow-up . | Predicted 10-year risk (original SCORE) . | Predicted 10-year risk (HAPIEE SCORE) . | Reclassified . | Net correctly reclassified . | ||||
<5% . | >5% . | Increased risk . | Decreased risk . | |||||
Died from CVD (n = 338) | ||||||||
<5% | 60 | 17 | 5% | −8.6% | ||||
>5% | 46 | 215 | 14% | |||||
Did not die from CVD (n = 14 260) | ||||||||
<5% | 8774 | 399 | 3% | 15% | ||||
>5% | 2551 | 2536 | 18% | |||||
Categorical net reclassification improvement (95% CI) | 0.07 | (0.02 to 0.11) | P = 0.005 | |||||
Continuous net reclassification improvement (95% CI) | 0.45 | (0.34 to 0.56) | P < 0.0001 |
CI, confidence interval; CVD, cardiovascular disease.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.